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Proteins that contain the DUF2874 domain constitute a new Pfam family
PF11396. Members of this family have predominantly been identified in
microbes found in the human gut and oral cavity. The crystal structure of
one member of this family, BVU2987 from Bacteroides vulgatus, has been
determined, revealing a -lactamase inhibitor protein-like structure with a
tandem repeat of domains. Sequence analysis and structural comparisons reveal
that BVU2987 and other DUF2874 proteins are related to -lactamase inhibitor
protein, PepSY and SmpA_OmlA proteins and hence are likely to function as
inhibitory proteins.
1. Introduction
Recent interest in metagenomics (Sleator et al., 2008), together with
advances in genomic and proteomic techniques, has led to a rapid
evolution in the study of the human gut microbiome (Frank & Pace,
2008; Ley et al., 2008; Verberkmoes et al., 2009) and its association
with human health and disease (Mai & Draganov, 2009; Kinross et al.,
2008; Turnbaugh et al., 2009; Ordovas & Mooser, 2006; Othman et
al., 2008; O’Keefe, 2008). The sequencing of complete genomes of
bacteria from the human gut, such as Bacteroides thetaiotaomicron
(Xu et al., 2003) and B. vulgatus (Xu et al., 2007), as well as from the
oral cavity, such as Porphyromonas gingivalis (Nelson et al., 2003),
has identified many novel proteins of unknown function. Large-scale
structure determination of these proteins can provide functional
insights and may lead to the identification of new drug targets for
therapeutic exploitation (Zaneveld et al., 2008).
Towards this goal, the BVU2987 protein from B. vulgatus ATCC
8482, one of the predominant members of the human gut micro-
biome, was selected for crystallographic structure determination.
BVU2987 is a 145-residue protein with a calculated pI of 5.36 and is
annotated as a putative periplasmic protein based on the predicted
N-terminal signal peptide. The protein sequence has been assigned to
a novel protein family that is predominately found in species that
populate the human oral cavity and gut microbiomes, including
Bacteroides, Campylobacter and P. gingivalis (the predominant agent
of periodontal disease). Proteins in this family are annotated either as
putative periplasmic proteins or as conserved hypothetical proteins,
but none have been biochemically characterized. Analysis of our
structure and of the available sequences shows that collectively this
family forms part of a larger superfamily of bacterial periplasmic
proteins that all adopt a fold similar to -lactamase inhibitor protein
(BLIP-like fold) and appear to share some broad spectrum of inhi-
bitory function.
2. Materials and methods
2.1. Protein production and crystallization
Clones were generated using the Polymerase Incomplete Primer
Extension (PIPE) cloning method (Klock et al., 2008). The gene
encoding BVU2987 (GenBank YP_001300247.1) was amplified by
polymerase chain reaction (PCR) from B. vulgatus ATCC 8482
genomic DNA using PfuTurbo DNA polymerase (Stratagene) and
I-PIPE (Insert) primers (forward primer, 50-ctgtacttccagggcGCGG-
ATGATGACAAACCTATTCAAG-30; reverse primer, 50-aattaagtc-
gcgttaATTGTCAATATCAATCACATTGAACTGC-30; the target
sequence is shown in upper case) that included sequences for the
predicted 50 and 30 ends. The expression vector pSpeedET, which
encodes an amino-terminal tobacco etch virus (TEV) protease-
cleavable expression and purification tag (MGSDKIHHHHHH-
ENLYFQ/G), was PCR-amplified with V-PIPE (Vector) primers
(forward primer, 50-taacgcgacttaattaactcgtttaaacggtctccagc-30; reverse
primer, 50-gccctggaagtacaggttttcgtgatgatgatgatgatg-30). V-PIPE and
I-PIPE PCR products were mixed to anneal the amplified DNA
fragments together. Escherichia coli GeneHogs (Invitrogen) com-
petent cells were transformed with the V-PIPE/I-PIPE mixture and
dispensed onto selective LB–agar plates. The cloning junctions were
confirmed by DNA sequencing. Using the PIPE method, the part of
the gene encoding residues Met1–Trp19 (predicted signal sequence)
was deleted. Expression was performed in selenomethionine-
containing medium at 310 K. Selenomethionine was incorporated via
inhibition of methionine biosynthesis (Van Duyne et al., 1993), which
does not require a methionine-auxotrophic strain. At the end of
fermentation, lysozyme was added to the culture to a final concen-
tration of 250 mg ml1 and the cells were harvested and frozen. After
one freeze–thaw cycle, the cells were homogenized in lysis buffer
[50 mMHEPES pH 8.0, 50 mM NaCl, 10 mM imidazole, 1 mM tris(2-
carboxyethyl)phosphine–HCl (TCEP)] and the lysate was clarified by
centrifugation at 32 500g for 30 min. The soluble fraction was passed
over nickel-chelating resin (GE Healthcare) pre-equilibrated with
lysis buffer, the resin was washed with wash buffer [50 mM HEPES
pH 8.0, 300 mM NaCl, 40 mM imidazole, 10%(v/v) glycerol, 1 mM
TCEP] and the protein was eluted with elution buffer [20 mM
HEPES pH 8.0, 300 mM imidazole, 10%(v/v) glycerol, 1 mM TCEP].
The eluate was buffer-exchanged with TEV buffer (20 mM HEPES
pH 8.0, 200 mM NaCl, 40 mM imidazole, 1 mM TCEP) using a PD-10
column (GE Healthcare) and incubated with 1 mg TEV protease per
15 mg of eluted protein. The protease-treated eluate was run over
nickel-chelating resin (GE Healthcare) pre-equilibrated with HEPES
crystallization buffer (20 mM HEPES pH 8.0, 200 mM NaCl, 40 mM
imidazole, 1 mM TCEP) and the resin was washed with the same
buffer. The flowthrough and wash fractions were combined and
concentrated by centrifugal ultrafiltration (Millipore) to 9.7 mg ml1
for crystallization trials. BVU2987 was crystallized using the nano-
droplet vapor-diffusion method (Santarsiero et al., 2002) with
structural communications
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Figure 1
Crystal structure of BVU2987 from B. vulgatus. (a) Stereo ribbon diagram of the BVU2987 monomer with the N-terminal domain in cyan and the C-terminal tandem-repeat
domain in pink. Helices H1–H4 (helices H1 and H3 are 310-helices and helices H2 and H4 are -helices) and -strands 1–8 are indicated. (b) Diagram showing the
secondary-structural elements of BVU2987 superimposed on its primary sequence. The -helices, 310-helices and -strands are indicated. The crystallized protein (including
residues 20–145) was expressed with a tag that was removed during purification, leaving Gly0 followed by the target sequence (starting from residue 20). (c) The electrostatic
surface potential reveals a prominent negatively charged region on the concave side of BVU2987 arising from the presence of numerous aspartic acid and glutamic acid
residues (Asp21, Asp22, Glu54, Asp56, Asp59, Asp63, Glu73, Glu82, Glu116, Asp118, Glu123, Glu131, Asp142 and Asp144). The color scale is in units of kT/e.
standard Joint Center for Structural Genomics (JCSG; http://
www.jcsg.org) crystallization protocols (Lesley et al., 2002). Sitting
drops composed of 200 nl protein solution mixed with 200 nl crys-
tallization solution were equilibrated against a 50 ml reservoir at
277 K for 37 d prior to harvesting. The crystallization reagent con-
sisted of 35.0%(v/v) 2-ethoxyethanol and 0.1M cacodylate pH 6.5.
No further cryoprotectant was added to the crystals. Initial screening
for diffraction was carried out using the Stanford Automated
Mounting system (SAM; Cohen et al., 2002) at the Stanford
Synchrotron Radiation Lightsource (SSRL). A rod-shaped crystal of
approximate size 20 20 100 mmwas harvested for data collection.
The diffraction data were indexed in the orthorhombic space group
P212121. To determine its oligomeric state in solution, BVU2987 was
analyzed using a 1  30 cm Superdex 200 size-exclusion column (GE
Healthcare) coupled with miniDAWN static light-scattering (SEC/
SLS) and Optilab differential refractive-index detectors (Wyatt
Technology). The mobile phase consisted of 20 mM Tris pH 8.0,
150 mM NaCl and 0.02%(w/v) sodium azide. The molecular weight
was calculated using ASTRA v.5.1.5 software (Wyatt Technology).
2.2. Data collection, structure solution and refinement
Multi-wavelength anomalous diffraction (MAD) data were
collected to 1.85 A˚ resolution on beamline 11-1 at SSRL at wave-
lengths corresponding to the high-energy remote (1), inflection
point (2) and peak (3) of a selenium MAD experiment using the
Blu-Ice data-collection environment (McPhillips et al., 2002). A beam
size of 0.15 0.15 mm was used during data collection. The 1 and 2
data sets were collected simultaneously interleaved in 30 wedges and
were followed by 3 (Gonza´lez, 2003a,b). The data set was collected
at 100 K using a MarMosaic 325 CCD detector (Rayonix). The MAD
data were integrated and reduced usingMOSFLM (Leslie, 1992) and
scaled with the program SCALA (Collaborative Computational
Project, Number 4, 1994).
The heavy-atom sites were located with SHELXD (Sheldrick,
2008) and phasing was performed with autoSHARP (Vonrhein &
Blanc, 2007). The heavy-atom substructure contained four anomalous
scatterers per asymmetric unit, with an overall figure of merit
(acentric/centric) of 0.39/0.33 and an anomalous phasing power for
the three wavelengths of 0.5–0.8. ARP/wARP (Langer et al., 2008)
was used for automatic model building. Model completion and
crystallographic refinement were performed with the 1 data set using
Coot (Emsley & Cowtan, 2004) and REFMAC5 (Collaborative
Computational Project, Number 4, 1994), respectively, with one TLS
group per molecule (Winn et al., 2003). Crystallographic data and
refinement statistics are summarized in Table 1.
2.3. Validation and deposition
The quality of the crystal structure was analyzed using the JCSG
Quality Control server (http://smb.slac.stanford.edu/jcsg/QC). This
server automatically processes the coordinates and data through a
variety of validation tools including AutoDepInputTool (Yang et al.,
2004), MolProbity (Lovell et al., 2003), WHAT IF v.5.0 (Vriend,
1990), RESOLVE (Terwilliger, 2003) and MOLEMAN2 (Kleywegt,
2000), as well as several in-house scripts, and summarizes the results.
Protein quaternary-structure analysis was performed using the PISA
server (Krissinel & Henrick, 2005). Fig. 1(b) was adapted from an
analysis using PDBsum (Laskowski et al., 2005) and all other figures
were prepared with PyMOL (DeLano, 2008). Atomic coordinates
and experimental structure factors for BVU2987 were deposited in
the PDB under the accession code 3due. Fig. 1(c) was prepared using
the PDB2PQR server (Dolinsky et al., 2007) and the APBS module
(Dolinsky et al., 2007; Baker et al., 2001) in PyMOL.
3. Results and discussion
3.1. Overall structure
The structure of BVU2987 was determined by MAD phasing to
1.85 A˚ resolution. The crystallized protein contained residues 20–145
of the full-length protein and an N-terminal glycine (that remained
after the cleavage of the expression and purification tag). A predicted
signal sequence (residues 1–19) was identified at the N-terminus of
the full-length sequence and was omitted from the construct used
for protein production. The final model contained one monomer,
one cacodylate anion (from the crystallization condition) and 133
water molecules in the asymmetric unit. The Matthews coefficient
(Matthews, 1968) is 2.3 A˚3 Da1, with an estimated solvent content
of47%. The Ramachandran plot produced byMolProbity (Davis et
al., 2004) showed that 96.8% and 100% of amino acids were in the
favored and allowed regions, respectively. Crystal-packing analysis
using PISA (Krissinel & Henrick, 2005), in addition to analytical size-
exclusion chromatography coupled with static light scattering, indi-
cated that the monomer was the favored oligomeric form in solution.
BVU2987 forms a crescent-shaped molecule comprised of an
eight-stranded antiparallel -sheet with four helices (two -helices
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Table 1
Crystallographic data and refinement statistics for BVU2987 (PDB code 3due).
Values in parentheses are for the highest resolution shell.
1 MAD-Se 2 MAD-Se 3 MAD-Se
Data collection
Space group P212121
Unit-cell parameters (A˚) a = 31.60, b = 50.87, c = 79.51
Wavelength (A˚) 0.9184 0.9793 0.9788
Resolution range (A˚) 29.4–1.85
(1.90–1.85)
29.4–1.85
(1.90–1.85)
29.4–1.85
(1.90–1.85)
No. of observations 40890 40928 41013
No. of unique reflections 11519 11544 11557
Completeness (%) 100.0 (100.0) 100.0 (100.0) 100.0 (100.0)
Mean I/(I) 8.8 (2.0) 9.2 (2.0) 8.7 (1.6)
Rmerge on I† (%) 10.9 (58.8) 10.4 (56.9) 11.2 (69.6)
Rmeas on I‡ (%) 12.9 (69.2) 12.2 (67.0) 13.2 (82.0)
Model and refinement statistics
Resolution range (A˚) 29.4–1.85
No. of reflections (total) 11480§
No. of reflections (test) 549
Completeness (%) 99.96
Data set used in refinement 1
Cutoff criteria |F | > 0
Rcryst} 0.192
Rfree} 0.233
Stereochemical parameters
Restraints (r.m.s.d. observed)
Bond angles () 1.65
Bond lengths (A˚) 0.015
Average isotropic B value†† (A˚2)
(all atoms/protein residues only)
22.4/21.2
ESU‡‡ based on Rfree (A˚) 0.14
Protein residues/atoms 126/1037
Waters/cacodylate 133/1
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Rmeas =
P
hkl ½N=ðN  1Þ1=2P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ (Diederichs & Karplus, 1997). § Typically, the
number of unique reflections used in refinement is slightly less than the total number
that were integrated and scaled. Reflections are excluded owing to negative intensities
and rounding errors in the resolution limits and unit-cell parameters. } Rcryst =P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj, where Fcalc and Fobs are the calculated and observed
structure-factor amplitudes, respectively. Rfree is the same as Rcryst but for 4.9% of the
total reflections chosen at random and omitted from refinement. †† This value
represents the total B that includes TLS and residual B components. ‡‡ Estimated
overall coordinate error (Collaborative Computational Project, Number 4, 1994;
Cruickshank, 1999).
and two 310-helices; Fig. 1a). The -sheet forms the inner concave side
of the crescent and the helices form the outer edge of this40 A˚ long
and 30 A˚ wide molecule. The monomer is formed by a tandem
repeat of a structural motif, possibly arising from a gene-duplication
event, comprised of four antiparallel -strands and a short helix–
loop–long helix. Thus, residues 28–85 and 92–145 can be super-
imposed with an r.m.s.d. of 1.7 A˚ and a sequence identity of 22% over
54 aligned C atoms. The -strands 1 and 2 in the first structural
motif are slightly longer than the corresponding structural elements
5 and 6 in the tandem repeat, whereas 3 is slightly shorter than 7
(Fig. 1b). Inspection of the electrostatic surface potential (Fig. 1c)
reveals that the concave surface has a prominent overall negative
charge, mainly owing to the presence of numerous aspartic and
glutamic acid residues.
Multiple orthologs of this protein family were targeted in parallel
for structure determination; the crystal structures of two other
proteins from this family were also determined and will be briefly
described here. The structure of BT0923 (UniProt Q8A994; PDB
code 3db7) from B. thetaiotaomicron VPI-5482 was determined at
1.40 A˚ resolution and that of BVU2443 (UniProt A6L337; PDB code
3elg) from B. vulgatus ATCC 8482 was determined at 1.64 A˚ reso-
lution; these proteins have 73 and 42% sequence identity to
structural communications
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Figure 2
Alignments of representative multiple sequence alignments of the DUF2874 (Pfam accession PF11396), PepSY (PF03413), BLIP (PF07467), SmpA_OmlA (PF04355) and
DUF3192 (PF11399) families. The alignments are colored according to the sequence conservation using CHROMA (Goodstadt & Ponting, 2001). The consensus sequence
for the individual families calculated by CHROMA at a 60% threshold is shown under each alignment. Gaps inserted to maintain local sequence alignment are denoted with
a ‘.’. Where appropriate, the PDB code and secondary structure is represented on a separate line under any sequence that has a known structure, with -helical residues
denoted ‘H’ and -strand residues denoted ‘E’. The sequences, which are shown using the UniProt accession code, are representative both in terms of the sequence and
species diversity. (a) Alignment of PepSYand DUF2487 families. (b) Alignment of the BLIP, SmpA_OmlA and DUF3192 families (N.B. the BLIP alignment is much shorter
than DUF3192 as it is restricted to the conserved core of the domain).
BVU2987, respectively. These proteins are both very similar and
superimpose on BVU2987 with r.m.s.d.s of 1.1 A˚ (over 122 aligned C
residues) and 1.7 A˚ (over 119 aligned C residues), respectively.
3.2. Sequence and structural comparisons
Detailed sequence and structural analyses of the crystal structure
of BVU2987 uncovered new relationships that unify the DUF2874
proteins into a superfamily of bacterial periplasmic proteins that
includes PepSY, BLIP, SmpA_OmlA and DUF3192 proteins. Remote
sequence similarities were first identified between DUF2874 and
PepSY-domain proteins and were followed by sequence relationships
between SmpA_OmlA, BLIP and DUF3192 that led to the
identification of structural similarities between DUF2874, BLIP,
SmpA_OmlA and PepSY proteins.
3.2.1. Sequence relationship between DUF2874 and PepSY-
domain proteins. After structure determination, sequence searches
against protein-domain databases, such as Pfam (Finn et al., 2008) and
the Conserved Domain Database (CDD; Marchler-Bauer et al.,
2007), with BVU2987 did not find any significant hits. However, a
BLAST (Altschul et al., 1997) search revealed several related
proteins (E value < 0.001). Regions that shared significant sequence
similarity to either tandem repeat, as defined by the structure, were
aligned using MAFFT (Katoh et al., 2005) and the resulting multiple
sequence alignment (representing a single domain) was used to
construct a profile hidden Markov model (HMM) using theHMMER
package (v.3.0, alpha release v.1.0). After multiple rounds of
searching the UniProt sequence database (v.12.5) using the HMM,
coupled with careful manual inspection of the resulting matches, we
identified 271 sequences (E value < 0.01) which form a new protein
family that has now been added to Pfam and appears in the new
release (Pfam 24.0, October 2009) as DUF2874 (Pfam accession
PF11396). These 271 DUF2874 domains are distributed in 153
distinct proteins from 40 species. In general, two copies of this domain
are usually found in each protein, although single copies, and even up
to four copies, also occur in some members of the family.
Interestingly, the most significant marginal matches (E-value range
0.01–0.1, below the set threshold of 0.01) matched the HMM of the
Pfam domain PepSY (Pfam accession PF03413). Inspection of these
marginal hits suggested that PepSY-domain proteins were likely to be
distant homologs of DUF2874. Profile–profile comparisons of all of
the latest Pfam HMMs against each other (Madera, 2008) indicated
significant similarity between the DUF2874 and PepSY families
(E value of 5.7 103). The sequence relationship is demonstrated in
the family pairwise sequence alignment in Fig. 2(a). In addition, the
presence of a signal peptide motif (predicted using PHOBIUS; Kall et
al., 2004) at the N-terminus and the repetitive nature of the domain in
some sequences are highly reminiscent of the domain architecture in
the PepSY family (Yeats et al., 2004). Unlike some members of the
PepSY family where the PepSY domain co-occurs with other
domains in the same protein (such as Peptidase_M4 and Pepti-
dase_M36), no additional domains were found to co-occur in proteins
structural communications
Acta Cryst. (2010). F66, 1265–1273 Das et al.  BVU2987 1269
Figure 2 (continued)
containing DUF2874 domains. Further analysis was carried out to
determine whether a single HMM could represent both DUF2874
and PepSY. However, a single model could not be built that was
sufficiently sensitive to detect all of the domains that could be found
using the two individual HMMs. This analysis demonstrates that
PepSY and DUF2874 domains represent either a single divergent
family or two related families of proteins that have arisen from a
common evolutionary ancestor. Interestingly, the profile–profile
comparisons also indicated that DsbC_N (Pfam accession PF10411),
an N-terminal domain found in disulfide-bond isomerase (DsbC)
proteins, may be related to DUF2874 (E value of 0.072). DsbC
proteins not only function as disulfide-bond isomerases during
oxidative protein folding in the bacterial periplasm, but have also
been implicated as chaperones (Hiniker et al., 2005). The structural
representative of the DsbC_N family (PDB code 1t3b; Zhang et al.,
2004; aligns with BVU2987 with an r.m.s.d of 2.5 A˚ over 45 C atoms)
is also found in the same SCOP fold as YpmB, a PepSY-family
protein (PDB code 2gu3; J. Osipiuk, N. Maltseva, I. Dementieva, S.
Moy & A. Joachimiak, unpublished work).
3.2.2. Sequence relationship between SmpA_OmlA, BLIP and
DUF3192 proteins. The recently determined first structural repre-
sentative (PDB code 2pxg; Vanini et al., 2008) of the SmpA_OmlA
structural communications
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Figure 3
Structural comparisons of BVU2987 with related proteins. (a) Comparison of BVU2987 (blue) with BLIP (gray). The sequence conservation between the two proteins is
<10% and among the functionally important residues (orange sticks) in BLIP only Lys74 is conserved in BVU2987 as Lys86 (magenta). Some of the important BLIP residues
are aromatic residues that are present in loops that do not have counterparts in BVU2987. However, a few aromatic residues are present in other loops in BVU2987 (pink
sticks) that could be functionally important. (b) Comparison of BVU2987 (N-terminal domain, blue) with OmlA protein (green; PDB code 2pxg). (c) Comparison of
BVU2987 (blue) with YpmB (PepSY-domain protein; yellow; PDB code 2gu3). Lys86 of BVU2987 (magenta) is conserved as Lys97 in YpmB (yellow) and is structurally
equivalent to Lys74 in BLIP, which is important in protein–protein interactions.
family of lipoproteins (Pfam accession PF04355) revealed structural
similarity to BLIP (Pfam accession PF07467). As in BVU2987, each
BLIP sequence contains a tandem repeat of a structural domain (four
antiparallel -strands and a short helix–loop–long helix), with the
structure of OmlA being superimposable on both the N-terminal and
C-terminal copies of this domain (Vanini et al., 2008). Given that the
structurally equivalent positions between OmlA and BLIP corre-
sponded to conserved residues among the BLIP sequences them-
selves, we took the Pfam BLIP HMMmodel from release 23.0 (which
represented BLIP as a continuous sequence rather than a domain
representing the tandem duplication) and modified it to represent the
repeated domain. A single search using this modified BLIP HMM
detected sequences from the SmpA_OmlA family, which highlighted
the presence of a common evolutionary ancestor. This updated
version of the BLIP family also appears in the new release of the
Pfam database (Pfam 24.0, October 2009).
Profile–profile comparisons were again used to identify additional
related families. These comparisons demonstrated that BLIP and
SmpA_OmlA are significantly similar (E value of 2.8  108) and
that both of these domains are also related to DUF3192 (Pfam
accession PF11399), with E values of 5.4  105 for BLIP and
8.6  105 for SmpA_OmlA. Representative sequence alignments
of each family over a similar region of the proteins (Figs. 2a and 2b)
demonstrate the sequence conservation between PepSY and
DUF2874 and between SmpA_OmlA, BLIP and DUF3192.
3.2.3. Structural relationship between DUF2874, BLIP, SmpA_
OmlA and PepSY proteins. A systematic search for other proteins of
similar structure to BVU2987 was conducted using several different
methods including the DALI server (Holm et al., 2008), the protein
structure-comparison service SSM at the European Bioinformatics
Institute (http://www.ebi.ac.uk/msd-srv/ssm; Krissinel & Henrick,
2005) and the flexible structure-alignment method implemented in
FATCAT (Ye & Godzik, 2004). The most prominent hit was to BLIP
(SCOP superfamily 55648 and SCOP fold 55647) from Streptomyces
clavuligerus (UniProt BLIP_STRCL), for which structures are
available in complex with Klebsiella pneumoniae SHV-1 -lactamase
(PDB code 2g2u and related entries; Reynolds et al., 2006), E. coli
-lactamase TEM-1 (PDB code 1jtg and the related entries 1s0w and
1xxm; Strynadka et al., 1996) and a putative BLIP from Streptococcus
mutans (PDB code 3d4e; Joint Center for Structural Genomics,
unpublished work). In the current Pfam PF07467/BLIP family, only
three protein sequences are present from two species: BLIP_STRCL
and P97062_STRCL from Streptomyces clavuligerus (with 31%
sequence identity to each other) and Q9KJ90_STREX from Strepto-
myces exfoliatus (with 37% sequence identity to BLIP_STRCL).
BLIP inhibits a wide variety of -lactamases (such as TEM-1, which is
the most widespread resistance enzyme to penicillin antibiotics).
BLIP_STRCL is larger than BVU2987 by about 50 residues, although
it also has an N-terminal signal sequence and is a secreted protein.
BVU2987 matches the different BLIP structures with DALI Z scores
of 5.5–6.5 and with r.m.s.d.s of 2.7–3.4 A˚ over 75% of the residues
(Fig. 3a). The antiparallel -sheet is conserved, although differences
are found in the size of the connecting loops and in the positioning of
the N-terminal helices. The loop between the two tandem structural
repeats is 10 residues long in BLIP and may contribute to its
binding flexibility and its ability to inhibit a variety of class A
-lactamases (Strynadka et al., 1996). This loop is of similar length in
BVU2987 and may confer similar flexibility.
Some of the important residues that have been implicated in the
interactions of BLIP with SHV-1 -lactamase (Reynolds et al., 2006)
are Glu31, Asp49, Lys74, Tyr115, Phe142, Tyr143, Trp150, Arg160 and
Trp162 (numbering after removal of the N-terminal signal sequence).
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Figure 4
Schematic of the structural and sequence relationships between families belonging to the BLIP-like superfamily. PepSY, DUF2487, BLIP and SmpA_OmlA structures were
rendered using OpenAstexViewer (Hartshorn, 2002). The structure is colored from blue at the N-terminus to orange at the C-terminus. For each family, a box indicates the
portion of the representative structure that corresponds to a single copy of the domain. The tandem domain arrangement is obvious for DUF2847 and BLIP, but less so for
PepSY owing to the different rotation of the second domain with respect to the first copy of the domain. SmpA_OmlA only has a single copy of the domain. No three-
dimensional structure is known for DUF3192. Relationships between the families that could be identified using sequence-based methods only are shown as gray arrows,
whereas strong structural similarity is indicated by solid black arrows and weak structural similar by dashed black arrows.
From the structural superposition (Fig. 3a), only Lys74 in BLIP is
conserved in BVU2987 as Lys86. Tyr115, Phe142 and Tyr143 in BLIP
are located in long loops. Although these aromatic residues are not
conserved in BVU2987, other aromatic residues (Trp57, Phe58,
Tyr122, Trp130 and Phe138) are present in the corresponding shorter
loops in BVU2987, which may be functionally important.
The concave surface of BVU2987 is negatively charged (Fig. 1b)
owing to the presence of numerous aspartate and glutamate residues.
In contrast, the concave surface of BLIP has numerous uncharged
polar residues (Ser35, Ser39, Tyr50, Tyr51, Tyr53, Thr55, Ser69, Ser71,
Thr110, Ser113, Ser128, Ser130 and Ser146). Of these, Ser39 and
Ser69 are conserved in BVU2987 as Ser61 and Thr81, respectively.
This surface of BLIP also includes Phe36, His41, Trp112, His148,
Trp150 and Trp162. It is interesting that the aromatic residues Tyr53,
Trp112 and Trp150 in BLIP are structurally equivalent to the basic
residues Lys71, Lys114 and Lys133 in BVU2987, respectively. It is
possible that the long aliphatic tail of the lysine residues may mimic
certain aspects of the hydrophobic tyrosine and tryptophan residues.
Loop L23 between strands 2 and 3 (residues 46–51) in the first
domain of BLIP is functionally important as Asp49 interacts with
four conserved active-site residues in TEM-1 -lactamase (Strynadka
et al., 1996), mimicking the interaction with the carboxylate group of
its substrate penicillin G. The corresponding loop in BVU2987 is
significantly shorter and is comprised of only two residues, 67–68.
Interestingly, BLIP is similar to the TATA-box-binding protein in
that it uses a tandem repeat of a structural motif of antiparallel
-strands to create a concave saddle-shaped surface that can bind to a
convex interacting partner (-lactamase and DNA, respectively;
Strynadka et al., 1996). For BVU2987, the negatively charged concave
surface is most likely to reflect binding to a positively charged
partner.
It has recently been shown that members of the OmlA (outer
membrane lipoprotein A) family are involved in the assembly of
outer membrane proteins and in maintaining the structure of the cell
envelope (Sklar et al., 2007), although the actual mechanism is
unknown. The structures of the BLIP-like domains of BVU2987
(residues 28–85) and the OmlA protein (PDB code 2pxg) super-
impose with a Z score of 0.9 and an r.m.s.d. of 2.6 A˚ over 35 C atoms
with 9% sequence identity (Holm & Park, 2000; Fig. 3b). Although
the Z score is below the standard significance cutoff of 2.0, OmlA
nevertheless has a BLIP-like fold (Vanini et al., 2008). Of the con-
served N-terminal QGN motif and the four aromatic residues in the
protein core that are seen in all OmlA proteins, only a single residue,
Phe74 (equivalent to Phe76 in OmlA), is found in BVU2987.
The BLIP-like domains of BVU2987 and YpmB (a member of the
PepSY family; PDB code 2gu3) superimpose with a Z score of 5.2 and
an r.m.s.d. of 2.9 A˚ over 58 C atoms with 9% sequence identity, but
the relative orientation of the tandem structural repeats in the two
proteins are different (Fig. 3c). Interestingly, Lys86 of BVU2987,
which is the counterpart of the functionally important Lys74 in BLIP
(mutation of this residue causes disruption of the BLIP–-lactamase
interface), is present as Lys97 in YpmB. Although the PepSY and
DUF2874 domains appear to be more closely related by sequence,
structural analysis indicates a greater similarity of DUF2874 to BLIP.
This may account for the discrepancy in the SCOP classification
where YpmB has been classified under a different SCOP fold, 54402.
3.3. Potential function based on similarity to related families
We have identified five bacterial periplasmic protein domain
families (DUF2874, PepSY, BLIP, SmpA_OmlA and DUF3192) that
are related by sequence and/or structural similarity (Fig. 4). BLIP
binds to numerous class A -lactamases and prevents them from
hydrolyzing -lactam antibiotics. Gene-knockout studies of BLIP in
Streptomyces exfoliatus SMF19 have indicated that BLIP may have a
broader role, particularly in regulating cell morphology (Kang et al.,
2000), which is thought to be mediated by its binding to penicillin-
binding proteins involved in cell-wall synthesis. Apart from BLIP, the
precise functions of these other families remain to be elucidated.
Nevertheless, a number of recurring themes appear to be emerging.
The PepSY domain, when found in combination with other Pfam
domains, is typically associated with M4 or M36 peptidases. These
peptidases all function in the periplasmic space and it has been
postulated that the PepSY domain functions as an inhibitor of the
peptidase. The same PepSY domain is also found in YpmB, which is
co-expressed with SleB (Boland et al., 2000). In this case, SleB, a lytic
enzyme, is inhibited by YpmB; given the lack of any sequence simi-
larity between the peptidase and this lytic peptide, it has been
suggested that PepSY may also function as a broad-spectrum inhi-
bitor (Yeats et al., 2004).
PepSYand DUF2874 domains are found in most protein sequences
where no other associated domains are present. The precise function
of OmlA remains unclear, but it is thought to be involved in main-
taining the integrity of the cell envelope (Ochsner et al., 1999). A
knockout study in Xanthomonas campestris pv. phaseoli indicated
that even though OmlA is divergently transcribed from the gene
encoding the ferric uptake regulator Fur, the absence of Fur does not
alter OmlA expression. In the same study, an OmlA mutant showed
increased susceptibility to novobiocin and coumermycin, which are
antibiotics with gyrase inhibitory activity. How OmlA protects the
cell against these antibiotics or maintains the cell envelope is not
known, but given the similarity to BLIP it is interesting to speculate
that a similar inhibitory/regulatory binding mechanism may be
employed in these two cases.
The BVU2987 structure is the first structural representative of a
novel protein family, which has now been added to the Pfam database
as DUF2874. The sequence and structural analyses presented show
that this family is a member of a superfamily containing four other
related bacterial periplasmic protein families: PepSY, BLIP, SmpA_
OmlA and DUF3192. The protein structures from these families all
adopt a BLIP-like fold. Although the precise functions of PepSY,
DUF2874, SmpA_OmlA and DUF3192 remain to be elucidated, it
seems that they function as inhibitors by binding a partner domain
located either on the same protein or on a separate protein. The
structure of BVU2987 reveals an internal duplication of a domain
that occurs between one and four times in different sequences. BLIPs
are important for the design of peptide-based -lactamase inhibitors
and for studying protein–protein interactions. Thus, the similarity
between these families opens up the possibility of biochemical studies
and therapeutic potential. Members of the DUF2874 family define a
new type of BLIP-like protein produced by the human gut micro-
biome. The structures of DUF2874 presented here can be used to
investigate whether these proteins do indeed inhibit -lactamases of
the human gut (Chanal et al., 1996). If so, these different BLIP-like
proteins could be utilized in the design of novel peptide-like
-lactamase inhibitors.
Additional information about BVU2987 is available from
TOPSAN (Krishna, 2010) at http://www.topsan.org/explore?PDBid
=3due.
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